Overview
Causaly provides AI biomedical research and drug R&D services.
Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record. Latest funding: $10M (Strategic), Oct 24, 2022.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Oct 24, 2022 | $10M · Strategic | 未披露 | No source link |
Evidence No source brief is attached to this record. Sources · 0
未披露 | |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Oct 24, 2022 | — · Strategic | 未披露 | No source link |
Evidence No source brief is attached to this record. Sources · 0
未披露 | |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
人工智能生物医学研究及药物研发服务商 Causaly是一家人工智能生物医学研究及药物研发服务商